Key result
ESC and NICE guidelines for stable angina prefer beta-blockers and calcium channel blockers as first-line treatment, despite all antianginal drugs being equally effective without reducing mortality.
Why the study?
Randomised trials show antianginal drugs are equally effective without reducing mortality or MI risk, yet guidelines differ in their approaches and prefer beta-blockers and calcium channel blockers as first-line therapy.
This critical review highlights the discrepancy between RCT evidence showing equal efficacy among antianginal drugs and current ESC/NICE guideline preferences for beta-blockers and calcium channel blockers as first-line therapy.
Answers are grounded in this paper and cite their sources.
Guidelines' first-line preference for beta-blockers and CCBs in stable angina lacks RCT superiority; leaves open whether recommendations warrant re-evaluation.
Most patients with stable angina can be managed with lifestyle changes, especially smoking cessation and regular exercise, along with taking antianginal drugs. Randomised controlled trials show that antianginal drugs are equally effective and none of them reduced mortality or the risk of MI, yet guidelines prefer the use of beta-blockers and calcium channel blockers as a first-line treatment. The European Society of Cardiology guidelines for the management of stable coronary artery disease provide classes of recommendation with levels of evidence that are well defined. The National Institute for Health and Care Excellence (NICE) guidelines for the management of stable angina provide guidelines based on cost and effectiveness using the terms first-line and second-line therapy. Both guidelines recommend using low-dose aspirin and statins as disease-modifying agents. The aim of this article is to critically appraise the guidelines' pharmacological recommendations for managing patients with stable angina.
No takes yet. Share an insight, caveat, or question.
Rousan et al. (2019) conducted a review in stable angina. Pharmacological therapy guidelines was evaluated. ESC and NICE guidelines for stable angina prefer beta-blockers and calcium channel blockers as first-line treatment, despite all antianginal drugs being equally effective without reducing mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: